Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Renal failure patients were treated with linezolid (LZD) for proven or suspected infections
by multiresistant Gram-positive cocci. The aim of this study is to determine if dose
adjustment of LZD is needed as a function of renal impairment or not, especially that a
significant component of LZD is eliminated unchanged in urine.